Adjunctive tiagabine treatment of psychiatric disorders: Three cases

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


Anticonvulsants which effectively treat complex partial seizures are noted to have mood stabilizing effects (carbamazepine, valproate, lamotrigine, gabapentin). Tiagabine, a novel GABA uptake inhibitor anticonvulsant with similar indications, was used as adjunctive therapy to control psychiatric symptoms in three patients - two with bipolar disorder and one with schizoaffective disorder, bipolar type. All three patients improved during adjunctive low dosage tiagabine treatment and no untoward side effects were noted. Clinicians are advised to consider this new anticonvulsant as a potential adjunctive agent in the treatment of bipolar and schizoaffective disorders. Controlled trials are indicated.

Original languageEnglish (US)
Pages (from-to)181-184
Number of pages4
JournalAnnals of Clinical Psychiatry
Issue number4
StatePublished - 1998

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health


  • Anticonvulsant
  • Bipolar
  • Pharmacotherapy
  • Schizoaffective
  • Tiagabine
  • Treatment


Dive into the research topics of 'Adjunctive tiagabine treatment of psychiatric disorders: Three cases'. Together they form a unique fingerprint.

Cite this